| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $16,930,233 ) (Continued on the next page) |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH120991 | Dysregulation of Appetitive & Aversive Amygdala Circuits in Bipolar Disorder | 000 | 5 | NIH | 2/26/2024 | $696,244 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH121617 | Mobile Measures of Threat Sensitivity for Cross-sectional and Longitudinal Assessment | 000 | 4 | NIH | 12/1/2023 | $699,731 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01NS109463 | Parkinsons Disease Scalable iPSC Autologous Cell Therapy | 002 | 5 | NIH | 4/9/2024 | $141,361 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01NS109463 | Parkinsons Disease Scalable iPSC Autologous Cell Therapy | 001 | 5 | NIH | 3/11/2024 | $0 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01NS109463 | Parkinsons Disease Scalable iPSC Autologous Cell Therapy | 000 | 5 | NIH | 12/29/2023 | $1,817,489 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116969 | Predicting the onset of depression in at-risk adolescents from endophenotype profiles | 000 | 5 | NIH | 12/4/2023 | $489,856 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R37MH068376 | Neuroimaging Studies of Reward Processing in Depression | 000 | 19 | NIH | 2/16/2024 | $685,634 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134074 | Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia | 000 | 1 | NIH | 2/29/2024 | $567,718 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | S10OD034308 | Electronics and Gradients Upgrade for an Agilent 9.4T/400mm Pre-clinical MR System | 000 | 1 | NIH | 2/29/2024 | $1,999,204 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135093 | Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology | 000 | 1 | NIH | 2/1/2024 | $761,943 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH136479 | Utilizing circRNA transcriptomics for functional characterization of psychiatric GWAS | 000 | 1 | NIH | 4/5/2024 | $246,000 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135899 | Leveraging Machine Learning Approaches to Understand Mechanisms of Exposure Therapy in Real-World Settings | 000 | 1 | NIH | 3/21/2024 | $720,689 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH132900 | Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression | 000 | 1 | NIH | 11/16/2023 | $178,416 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS129188 | Human iPSC-Based Personalized Cell Therapy of PD | 000 | 2 | NIH | 4/9/2024 | $668,428 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 001 | 2 | NIH | 4/11/2024 | $0 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 000 | 2 | NIH | 3/21/2024 | $664,686 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K08MH130802 | Understanding Foxp2-Mediated Molecular Signaling in Fear Learning | 000 | 2 | NIH | 4/8/2024 | $193,993 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH131881 | Building normative models of Reinforcement Learning Decision Making Behavior | 000 | 2 | NIH | 11/17/2023 | $184,500 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21NS131692 | Preclinical evaluation of the D2 receptor agonist MCL-524 as diagnostic marker for presymptomatic Parkinson's Disease | 000 | 2 | NIH | 4/22/2024 | $205,000 |
| | 2024 | 2024 | MCLEAN HOSPITAL CORPORATION, THE | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH129828 | Multimodal characterization of affective visual processing in the early aftermath of trauma | 000 | 2 | NIH | 10/18/2023 | $179,707 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 000 | 2 | NIH | 2/15/2024 | $664,987 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD112293 | Elucidating interactions among early life adversity, sleep architecture, and immune function | 001 | 4 | NIH | 3/20/2024 | $7,499 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD112293 | Elucidating interactions among early life adversity, sleep architecture, and immune function | 000 | 4 | NIH | 12/14/2023 | $86,378 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA054113 | The Role of Behavior Therapy Combined with Buprenorphine for the Treatment of Opioid Use Disorder | 000 | 3 | NIH | 4/23/2024 | $350,550 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 000 | 3 | NIH | 10/31/2023 | $604,336 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01HD104656 | Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics | 000 | 3 | NIH | 4/5/2024 | $412,487 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH126193 | Interpretation Bias as a Mechanism of Treatment Response in OCD | 000 | 3 | NIH | 12/15/2023 | $181,688 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH125740 | SCH: INT: Collaborative Research: Context-Adaptive Multimodal Informatics for Psychiatric Discharge Planning | 000 | 4 | NIH | 2/26/2024 | $249,004 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH125740 | SCH: INT: Collaborative Research: Context-Adaptive Multimodal Informatics for Psychiatric Discharge Planning | 001 | 4 | NIH | 4/2/2024 | $0 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH123993 | Synaptic and neuronal mechanisms of fear control: the role of hippocampal-amygdalar interactions | 000 | 5 | NIH | 3/8/2024 | $437,662 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH119227 | Multimodal Approaches to Neurobiology of Traumatic Dissociation | 000 | 5 | NIH | 1/10/2024 | $685,214 |
| | 2024 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH119467 | Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making | 000 | 5 | NIH | 3/19/2024 | $2,836,693 |
| | 2024 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | RF1AG078304 | Cloud-Based Big Neuroimaging Data Resource for Harmonized Research on Neuropsychiatric Symptoms in Alzheimer's Disease | 000 | 1 | NIH | 12/22/2023 | $16,000 |
| | 2024 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | F32MH127812 | Precisely quantifying the dynamic impact of sleep quality on cognitive fluctuations | 000 | 2 | NIH | 2/26/2024 | -$34,540 |
| | 2024 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH125920 | A Multi-Modal Investigation of Neurophysiological Deficits in PTSD | 001 | 3 | NIH | 2/21/2024 | -$72,624 |
| | 2024 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH125920 | A Multi-Modal Investigation of Neurophysiological Deficits in PTSD | 000 | 3 | NIH | 2/21/2024 | -$37,557 |
| | 2024 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DK121240 | Glycemic Variability and Fluctuations in Cognitive Status in Adults with Type 1 Diabetes | 000 | 4 | NIH | 3/27/2024 | $0 |
| | 2024 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG060195 | Prevention of complement and immune-mediated Lewy body dementia | 000 | 5 | NIH | 12/21/2023 | $0 |
| | 2024 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH116033 | Emotion Regulation in Depression and the Aging Brain | 000 | 6 | NIH | 2/19/2024 | $0 |
| | 2024 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R56NS127391 | Crosstalk between Nurr1 and risk factors of Parkinson's disease and its regulation by Nurr1's ligands | 000 | 1 | NIH | 2/8/2024 | $0 |
| | 2024 | 2022 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH125850 | Individualized brain systems and depression | 002 | 1 | NIH | 1/12/2024 | -$371,699 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K25DA045954 | Assessing the Impact of Cannabis Use on the Brain | 000 | 3 | NIH | 10/13/2023 | -$77,899 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R33DA042847 | Reduction in frequency of drug use as a primary outcome and its relation to changes in health-related and other functional outcomes in stimulant use disorder trials | 000 | 5 | NIH | 11/17/2023 | $0 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R24OD024622 | Biorepository of iPSC lines from diverse rat strains for regenerative medicine research | 000 | 4 | NIH | 2/13/2024 | -$6 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | U01MH116925 | Robust Predictors of Mania and Psychosis | 000 | 4 | NIH | 2/9/2024 | $0 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA041866 | Brain effects of long-term anabolic-androgenic steroid use:Multimodal imaging and cognition studies | 000 | 5 | NIH | 1/23/2024 | -$276 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA045000 | Neurobiological mechanisms of prescription opioid withdrawal | 001 | 5 | NIH | 10/13/2023 | -$286 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA045000 | Neurobiological mechanisms of prescription opioid withdrawal | 000 | 5 | NIH | 10/13/2023 | -$1,203 |
| | 2024 | 2021 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH110379 | Non-Suicidal Self-Injury in Children: Brain/behavior Alterations and Risk for Suicidal Behavior | 000 | 6 | NIH | 3/1/2024 | $0 |
|
